Document is current
Any future updates will be listed below
-
Authors
Gong, Yuxing
Ding, Yufei
Yang, Jingyi
Ding, Tao
Li, Bin
Ma, Junfeng
Shah, Wahid
Deng, Youcai
Duan, Ping
Zhang, Yu
Gao, Yuan
-
Funding
Funding for this research was provided by:
The National Key Research and Development Program of China grant (2020YFA0113500)
Natural Science Foundation of Chongqing City grant (CSTB2022NSCQ-MSX0833)
National Natural Science Foundation of China grant (82371047)
Joint Funds of the National Natural Science Foundation of China grant (U23A20436)
The Key Program of Shanxi Province grant (202302130501008)
Shanxi Provincial Science Fund for Distinguished Young Scholars grant (202103021221008)
Key Innovation Teams of Shanxi Province grant (202204051001023)
Shanxi Provincial Foundation for Leaders of Disciplines in Science grant (2024Q014)
The Shanxi Provincial Foundation for Returned Scholars (2022-117)
- License Information
-
More Information
Article History
Received: 23 July 2025
Accepted: 28 January 2026
First Online: 5 February 2026
Declarations
:
: The authors declare no competing interests.
: Human umbilical cord mesenchymal stem cells (UCMSCs) were approved by Shanxi Medical University (approval number: 2023SJL66) and conducted in accordance with the local legislation and institutional requirements. All animal experiments were approved by the Animal Care Committee of Shanxi Medical University (approval number: 2023-133) and conducted according to the institution’s laboratory animal welfare guidelines.
